Form 4: Acadia Healthcare Director Granted 6,625 Shares

Acadia Healthcare Company Director Daniel J. Cancelmi was granted 6,625 shares of common stock, vesting over a three-year period.

Summary

• Daniel J. Cancelmi, a Director of Acadia Healthcare Company, Inc. (ACHC), acquired 6,625 shares of common stock.
• The transaction date for this acquisition was March 12, 2026.
• The shares were acquired at a price of $0.00 per share, indicating a grant rather than a purchase.
• Following this transaction, Daniel J. Cancelmi beneficially owns 6,625 shares directly.
• The acquired shares will vest over a three-year period in equal annual installments, commencing on March 12, 2027.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it represents a routine compensation event that strengthens the alignment of a director's financial interests with the long-term performance of Acadia Healthcare.

Positives

• The grant of shares to a director aligns management's interests with those of shareholders, encouraging long-term value creation.

Future Outlook

The shares granted to Director Daniel J. Cancelmi are subject to a three-year vesting schedule, with equal annual installments beginning March 12, 2027, indicating a future commitment and alignment with long-term company performance.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the healthcare industry and across public companies, serving as a key component of compensation packages designed to incentivize long-term performance and align leadership interests with shareholder value.

Comparison to Industry Standards

• Equity compensation for directors, such as restricted stock units or stock options, is a standard practice across publicly traded companies, including those in the healthcare sector like Universal Health Services (UHS) or HCA Healthcare (HCA).
• The three-year vesting period is typical for such grants, aiming to retain talent and ensure sustained commitment to company performance, comparable to vesting schedules seen at peers.

Stakeholder Impact

• Shareholders: The grant of shares to a director can be seen as positive, as it aligns the director's financial incentives with the company's long-term stock performance, potentially benefiting shareholders.

Next Steps

• The shares will vest over a 3-year period in equal annual installments beginning March 12, 2027.

Key Dates

Keywords

Acadia Healthcare, ACHC, Insider Transaction, Form 4, Director Compensation, Stock Grant, Equity Award, Vesting